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Optogenetics is a powerful technique that allows target-specific spatiotemporal manipulation
of neuronal activity for dissection of neural circuits and therapeutic interventions. Recent
advances in wireless optogenetics technologies have enabled investigation of brain circuits in
more natural conditions by releasing animals from tethered optical fibers. However, current
wireless implants, which are largely based on battery-powered or battery-free designs, still
limit the full potential of in vivo optogenetics in freely moving animals by requiring inter-
mittent battery replacement or a special, bulky wireless power transfer system for continuous
device operation, respectively. To address these limitations, here we present a wirelessly
rechargeable, fully implantable, soft optoelectronic system that can be remotely and selec-
tively controlled using a smartphone. Combining advantageous features of both battery-
powered and battery-free designs, this device system enables seamless full implantation into
animals, reliable ubiquitous operation, and intervention-free wireless charging, all of which
are desired for chronic in vivo optogenetics. Successful demonstration of the unique cap-
abilities of this device in freely behaving rats forecasts its broad and practical utilities in
various neuroscience research and clinical applications.
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Unveiling the working mechanisms of the brain can opennew opportunities for the treatment of brain disordersand neurodegenerative diseases1–5. Optogenetics6—using
light to engage biological systems with exogenously expressed
light-sensitive proteins—is an emerging neuroscience tool, which
can modulate neuronal populations in a highly selective way. This
powerful technique allows precise activation or inhibition of
specific types of neurons, thus providing the ability to explore
neuronal functions and related signal pathways at the circuit level
in the central and peripheral nervous systems7. However, con-
ventional approaches for optogenetics involve tethered optical
fibers for light delivery, which significantly restrict animals’
movement, cause increased inflammation in soft brain tissue
owing to their rigid mechanics, and lack scalable control cap-
ability for in vivo studies involving multiple animals8,9.
Advancements in materials and micro/nanofabrication techni-
ques have enabled ultrathin neurophilic probes10–12 and multi-
functional polymeric fibers13,14 that allow chronic biocompatible
integration with neural tissue, but they still rely on leashed setups
with bulky equipment, thus restricting their full capabilities.
Recent developments of wireless optogenetic devices have tried
to abate limitations associated with the tethered approach9,15–27.
Current wireless technologies largely rely on battery-powered15–19
or battery-free approaches20–27. Battery-powered devices provide
a stable stand-alone power solution but require intermittent
replacement of batteries for continuous operation, thereby
necessitating head-mounted configurations vulnerable to external
stress15–19. Battery-free implants with miniaturized radio-
frequency (RF) energy-harvesting circuits, on the other hand,
overcome this limitation by allowing their full implantation inside
the body22–27. However, their wireless operation is susceptible to
angular orientations, does not support selective control among
multiple animals mingled together, and most importantly, always
requires special bulky cages equipped with an RF power transfer
system. These features substantially constrain diverse behavioral
experiment setups for complex neuroscience research and frus-
trate possible future use of this technology in daily human life for
therapeutic interventions. Some recent advances have tried to
combine batteries with a wireless energy-harvesting module in
implantable systems to enable wireless charging of batteries.
However, their bulky and rigid configurations limit biomechani-
cally compatible chronic use within the body, and moreover, the
wireless charging capability in freely moving animals has not been
demonstrated28,29.
To overcome these challenges and maximize the use of wireless
optogenetics, we present a fully implantable, soft, wirelessly
rechargeable optoelectronic systems that can be conformally
integrated within the body and can be easily controlled by a
readily available smartphone. This implant combines the advan-
tages of both state-of-the-art battery-powered (head-mounted)
and battery-free (fully implantable) devices while overcoming the
fundamental limitations of each approach (see Supplementary
Table 1 for detailed comparison with contemporary technolo-
gies). More specifically, our integrated devices are powered by a
subcutaneously implanted, wirelessly rechargeable battery and
controlled using bluetooth low energy (BLE) wireless technology.
This combination allows not only minimalistic experimental
setups without requiring special cages for reliable device opera-
tion, but also enables highly versatile wireless controls such as
simultaneous selectivity within multiple animal cohorts, omni-
directional wireless operation, and closed-loop control. Further-
more, the design incorporating a wirelessly rechargeable battery
system completely eliminates the need for disruptive periodic
surgeries for replacement of batteries, which is a big pain stake for
patients, implanted with battery-operated devices such as deep
brain stimulators and pacemakers, thus allowing intervention-less
chronic in vivo operation. Our in vivo studies with freely
behaving animals and phantom human models demonstrate the
broad utility and immense potential of wirelessly rechargeable
implants for neuroscience research and clinical applications.
Results
Design and operational principles. Figure 1a shows an exploded
view schematic diagram of a wirelessly rechargeable, smartphone-
controlled optoelectronic system (see the Methods section and
Supplementary Fig. 1 for fabrication details). The wireless
optoelectronic system consists of four main functional parts: (i)
optoelectronic neural probes for photostimulation, (ii) a power
management circuit with a flexible coil antenna and a recharge-
able Lithium Polymer (LiPo) battery (GMB-300910, PowerStream
Technology) for wireless charging and operation, (iii) Bluetooth
Low Energy System-on-Chip (BLE SoC; RFD77101, RF Digital
Corporation) for wireless control, and (iv) soft polymer encap-
sulation for biocompatible device packaging. The power man-
agement circuit with a coil antenna primarily helps harvest
wireless RF energy to form DC electrical charging currents for the
LiPo battery (12 mAh, 0.3 g). The coil antenna (16 turns dis-
tributed on two interconnected layers) is constructed by pat-
terning copper traces (35 μm thick) on thin polyimide (PI; 25 μm
thick) layers. The bilateral neural probes integrate microscale
inorganic light-emitting diodes (μ-ILEDs; blue (470 nm), 270 ×
220 × 50 μm3; Supplementary Fig. 2), which are controlled by the
BLE SoC to enable wireless optogenetic modulation in both left
and right sides of the brain. Each probe is 100 μm-thick and
300 μm-wide, making its cross-sectional area similar to that of
single-mode optical fibers (0.03 mm2 for an optoelectronic probe
vs. 0.042 mm2 for an optical fiber). Previous studies demonstrated
biocompatibility and long-term in vivo stability of this type of
optoelectronic probes in brain tissue17,19,20,23,24. Soft polymer
encapsulation has a key role in not only providing device pro-
tection from bio-fluids and external shock, but also allowing
conformal bio-integration for adaptive and reliable operation
inside the body. The encapsulation consists of multiple polymer
layers. The inner encapsulation layers are composed of poly-
dimethylsiloxane (PDMS; 600 μm thick) and Parylene C (7 μm
thick, 0.083 g mmm–2 day–1 water vapor permeability) and work
as a protection barrier against biofluid, while the outer ultrasoft
polymer (33.4 kPa, 1400 μm thick; Ecoflex GEL, Smooth-On Inc.)
offers a biocompatible mechanical buffer for seamless chronic
integration with tissue (Supplementary Fig. 3). All the materials
and electronic components are commercially available and can be
processed and assembled using standard fabrication techniques,
thus facilitating mass production and deployment of devices for
neuroscience research.
The circuit diagram of the overall wireless system is illustrated
in Fig. 1b. Both a wireless power transmitter (Fig. 1b, top) and a
wireless receiver (i.e., wireless optoelectronic device; Fig. 1b,
bottom) are designed to match the resonant frequency at
6.78 MHz, following the Alliance for Wireless Power (A4WP)
standard, which is broadly used for simultaneous wireless
charging of multiple devices. As the coil antenna of the device
receives the wirelessly transmitted power via inductive coupling,
it supplies a rectified and multiplied voltage to the battery for
energy harvesting through a voltage-doubler circuit. To prevent
undesired discharging of the battery by reverse-flow of the
current, the battery located at the load is connected with a
Schottky diode in series. The wirelessly charged battery then
delivers stable DC power to BLE SoC and μ-ILEDs for their
reliable wireless operation.
Figure 1c–f highlights various features and operational concepts
of fully implantable, wirelessly rechargeable optoelectronic
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-20803-y
2 NATURE COMMUNICATIONS |          (2021) 12:535 | https://doi.org/10.1038/s41467-020-20803-y | www.nature.com/naturecommunications
Fig. 1 Design and working principles of fully implantable, wireless rechargeable, soft optoelectronic systems for in vivo optogenetics. a Exploded view
schematic diagram of a soft wireless optoelectronic system with bilateral probes, consisting of microscale inorganic light-emitting diodes (μ-ILEDs), a
power management circuit, radiofrequency (RF) coil antennas, a battery, and a Bluetooth Low Energy System-on-Chip (BLE SoC). b Electrical circuit
diagram of the overall power regulation system, which consists of a wireless power transmitter and a wireless rechargeable optoelectronic system (i.e.,
wireless receiver). c Optical image of a wireless optoelectronic system held with fingers. The inset shows that the device is smaller than a US quarter.
d Conceptual illustration of a wireless optoelectronic probe system subcutaneously implanted in a rodent head for control of neural circuits deep in the
brain. The inset highlights conformal integration of the device with a rat brain. e X-ray image of a rat implanted with a wireless optoelectronic system.
f Operation principles of wireless optoelectronic systems in two different scenarios. The wireless implants can operate in (i) a cage equipped with a closed-
loop RF auto-charging system for chronic in vivo study, or (ii) any conventional experimental setup without needing a special RF power transmitter, using
the integrated battery. In all cases, a custom-designed smartphone app allows user-friendly control of the wireless implants.
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systems. The compact and lightweight electronic design (Fig. 1c;
1.4 g; 19 mm-long × 12mm-wide × 5mm thick) allows seamless
integration of the device inside the body of small animals such as
rodents and allows their undisturbed naturalistic behavior and
movement (Fig. 1d and e and Supplementary Fig. 4). The former
feature of the device, when compared with contemporary head-
mounted systems15–21, substantially reduces the risk of device
damage and unwanted stress on the tissue where the device is
implanted, which may be caused by heavy interactions between
animals especially in group housing conditions and/or by chance
of bumping the device on rigid cages during free movement. In
addition, the approach of integrating wireless power transfer with
a rechargeable battery provides unique attributes that make it
surpass existing battery-powered and battery-free wireless tech-
nologies. One of the most important features of this design is that
wireless recharging capability completely removes the need for
intermittent replacement of batteries, opening opportunities for
non-disruptive chronic in-body operation. Furthermore, powered
by an integrated battery, the device enables operations indepen-
dent of environment and power setup, making their use more
versatile. Some possible scenarios of its use in behavioral
neuroscience research are illustrated in Fig. 1f. The devices can
be wirelessly charged while animals move freely in a home cage
equipped with a wireless closed-loop auto-charging system. Once
devices are fully charged, animals can be placed in “any”
experimental setup (i.e., no need for a power transfer setup),
thereby facilitating their wide deployment for numerous neu-
roscience studies. In all cases, using a custom-designed smart-
phone app, μ-ILED operation (5−40 Hz with 10ms pulse width)
can be controlled wirelessly, and the battery level can be
monitored in real-time through BLE communication (Fig. 1f,
Supplementary Fig. 5, and Supplementary Movie 1). BLE is an
attractive wireless control scheme for neuroscience research,
which overcomes limitations of both IR15,17,18 and other RF
wireless controls20–27. Some of the advantages of BLE control
include highly selective control of single or multiple animals
within the vicinity, no line-of-sight handicap, long working
distance (up to ~100m), and bidirectional communication that
enables closed-loop control, as demonstrated in our simulation
experiment (Supplementary Fig. 6). All the aforementioned
characteristics make this tool highly versatile and potent option
for chronic in vivo applications in neuroscience research.
Electrical characteristics of wireless battery charging systems.
The soft optoelectronic implants can be recharged wirelessly via
inductive coupling at 6.78 MHz, while animals stay in their native
home cages. Figure 2 shows the electrical characteristics of the
wireless battery charging systems under various operational
conditions in a typical rat cage (39.6 × 34.6 × 21.3 cm3) installed
with three RF coil antennas located at the top (blue, 21.3 cm
height), side (green, heights of 4, 8, and 12 cm), and bottom (red,
0 cm height) (Fig. 2a). The antennas are designed to be integrated
with a rat cage through a simple assembly process (Supplemen-
tary Fig. 7) to allow facile and rapid setup for different cages with
the same dimensions. In the RF transmitter design, the side
antenna alone or the top and bottom antennas without the side
antenna are not sufficient for effective wireless charging of the
devices implanted in freely moving rodents due to either rela-
tively weak magnetic field generation (Supplementary Fig. 8a) or
field vacancy in 3D space (Supplementary Fig. 8b), respectively.
By operating all three antennas simultaneously, the wireless
charging system can supply magnetic fields strong enough to
cover all over the 3D space within the cage (Fig. 2b, Supple-
mentary Fig. 8c, and Supplementary Movie 2), thereby supporting
omni-locational energy harvesting.
Wireless optoelectronic devices (i.e., receivers) are designed to
effectively scavenge transmitted RF power regardless of their
locations and angles within the cage. Figure 2c shows the rectified
voltage and the delivered power to the load of a wireless device
with different load resistances at the cage center (6 cm height)
when 12.5W input power is supplied to the transmit loop
antennas of the cage. The peak delivered power (~5.3 mW) can be
obtained at a voltage of ~5 V, which is achieved by rectification
and multiplication through the wireless power management
circuit (Fig. 1b, red dotted box). Overall, these devices show some
degree of variation in wirelessly received power depending on
their locations (center, edge, and corner), heights (3 cm, 6 cm,
9 cm, and 12 cm above the ground), and angular orientations
(0°, 30°, 60°, and 80° with respect to horizontal plane) inside the
cage, demonstrating a clear inverse relationship between the
angular orientation and the received power across the 3D space
(Fig. 2d, e). However, there is no dramatic decrease in energy-
harvesting efficiency even at very high angular orientation (80°)
or with height changes towards the middle space of the cage,
thereby allowing stable wireless charging of the battery. This is
owing to the combinatorial antenna design setup that combines
fields from the top, the side, and the bottom coils to offer effective
field coverage in space and direction within the cage.
A proof-of-concept experiment verifies the device capabilities
for wireless charging. To simulate in vivo operation, we immersed
the device in saline water (0.9%) and characterized the battery
charging behavior at various locations inside the cage (Fig. 2f and
Supplementary Fig. 7b). For all cases, 45 min was enough to
charge the battery (~3.7 V) to operate a μ-ILED at 5− 40 Hz with
a 10 ms pulse width for >40 min (Supplementary Fig. 9a, b). This
means that charged devices can be operated anywhere and
anytime without relying on the power transfer setup anymore,
thus overcoming the critical limitation of current implantable,
battery-free wireless device technologies22–27. Note that the
device operation time can be further increased by employing a
battery with a larger capacity and/or a more advanced low power
BLE SoC (Supplementary Fig. 9c, e).
The optoelectronic devices can also be automatically charged
wirelessly through a closed-loop system integrated with the RF
power transmitter (Fig. 1b, yellow dotted box). The wireless auto-
charging system (Fig. 1f, middle) continuously monitors the
battery level of the devices through Bluetooth communication
and turns on the RF transmitter for wireless power transfer if the
battery level goes below 15% (Supplementary Fig. 10). This
closed-loop charging scheme prevents the battery from being fully
discharged, thereby making the devices always on standby for
wireless triggering. Figure 2g and Supplementary Movie 3 show a
proof-of-principle demonstration of the automatic wireless
charging of the devices. Real-time measurement of the battery
voltage level of the devices during operation within a wireless
charging cage verifies the capability of the wireless closed-loop
system, which will not necessitate physical interference with freely
moving animals during behavioral experiments.
Mechanical and thermal characteristics of soft wireless optoe-
lectronic systems. Wirelessly rechargeable optoelectronic systems
are packaged into a soft, tissue-compatible device platform that
can adapt to deformation and conform to curvilinear surfaces
inside the body. The soft packaging platform consists of a thin
bilayer (core) of PDMS (0.6 mm) and Parylene C (7 μm), which
acts as a waterproof barrier against biofluid penetration, and an
outer ultrasoft silicone gel (shell; Ecoflex GEL, Smooth-On Inc.;
33.4 kPa; 1.4 mm), which works as a mechanical buffer (Fig. 3a).
This core/shell soft polymer composite system provides several
key features for fully implantable systems; it offers (i) perfect
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Fig. 2 Electrical characteristics of wireless rechargeable optoelectronic systems. a, b Schematic diagram (a) and simulated magnetic field density (B) (b)
of a rat cage (39.6 cm (W) × 34.6 cm (L) × 21.3 cm (H)) with three loop antennas (top, side, and bottom antenna). c Measurement of rectified voltage
(blue line) and power delivered to the load (red line) of a wireless device with different load resistances (from 7–30 kΩ), which was placed at the center
with a 6 cm height above the ground of the rat cage. The maximum output power (~5.3 mW) was obtained with a 4.7 kΩ load resistance, when an input
power of 12.5W was transmitted. d Normalized power at the output load (4.7 kΩ) of wireless devices at various locations (center, edge, and corner),
heights (3, 6, 9, and 12 cm) and orientations (0°, 30°, 60°, and 80°) inside a rat cage. e Variation of energy-harvesting efficiency with respect to location
and angular orientation of a device at a height of 6 cm in the rat cage. f Wireless battery charging characteristics in saline water (0.9%) at various heights
(0, 3, 6, 9, and 12 cm) for the device located at the center (left) and the corner (right) of the cage. Battery charging was started after the battery was fully
discharged. g Real-time monitoring of the battery level during the wireless closed-loop auto-charging operation of the optoelectronic system in two
different sequential scenarios: wireless auto-charging (i) without and (іі) with LED operation. When the battery voltage level reaches the preset maximum,
charging is automatically turned off temporarily for 10 s to confirm whether the battery is actually fully charged (see small dimple in the recorded signal at
22 min). The small fluctuation of the battery voltage level appearing between 58 and 80min is due to electrical noise caused by the LED operation. The
proof-of-principle operation was carried out with a device immersed in saline water (0.9%), which was located at the center of the rat cage floor.
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conformal integration with curved body surfaces, (ii) thermo-
mechanical compatibility between the implant and soft brain
tissue, (iii) protection of the electronic system from biofluid, and
(iv) light device weight that cannot be achieved using conven-
tional encapsulation materials such as metals and glass. Figure 3b
shows optical images of polymer-encapsulated devices (5 mm in
total thickness) conformally interfaced with curved surfaces of a
rat skull (left) and a hemispherical structure (right; the radius of
curvature of 35 mm). Further, as shown in Fig. 3c and Supple-
mentary Fig. 11, the extent of contact on the curved surface is
enhanced with an increasing thickness of the outer ultrasoft
silicone layer, saturating to peak values with a total encapsulation
thickness of 2 mm (1.4 mm thick Ecoflex GEL shell and 0.6 mm-
thick PDMS core). With this encapsulation, the devices can make
perfect conformal integration with any surface with a radius of
curvature of 35 mm or greater without bending the device
Fig. 3 Mechanical and thermal characteristics of soft wireless rechargeable optoelectronic implants. a Schematic diagram of an implant encapsulated
with soft biocompatible polymers (top) and its cross-sectional view (bottom). b Optical images of the implant conformally mounted on a rat skull (left) and
a half-cylinder structure with a radius of curvature of 35mm (right). The insets show the zoomed-in images of the device edge, highlighting perfect
conformal integration with the curved surfaces. c Extent of conformal contact on half-cylinder structures with various radii of curvature (5–50mm) for the
devices with silicone gel encapsulation with different thicknesses (tshell= 0.4, 1.4, and 2.4mm). d Mechanical stress as a function of compression for
devices coated with silicone gel with different thicknesses (tshell= 0.4, 1.4, and 2.4 mm). e Transverse effective Young’s modulus (Eeff) of devices coated
with three common elastomers (PDMS, Ecoflex, and Ecoflex GEL) as a function of the encapsulation thickness (left) (n= 3). The zoomed-in graph (right)
highlights the significantly low effective Young’s modulus of a device with Ecoflex GEL encapsulation, compared with devices coated with PDMS or Ecoflex.
Error bars indicate maximum and minimum values. f Infrared images showing surface temperature of devices without (top) and with (bottom) polymer
encapsulation before (left) and during (right) wireless charging and μ-ILED operation (40 Hz, 10 ms pulse width). The measurement was made in an
ambient environment at room temperature. g Temperature of explanted brain tissue with a μ-ILED operated at different pulse frequencies (5, 10, 20, and
40Hz; 10ms pulse width) at 1 mm beneath the tissue surface (inset). To mimic a biological environment, the baseline temperature of the explanted brain
tissue was maintained at 36.5 °C using a heater. h Battery voltage level as a function of time during repeated device operation—that is, repetition of
wireless charging (60min) and μ-ILED operating (20 Hz, 10ms pulse width)—after immersing the devices in saline water with temperatures of 37 °C
and 90 °C.
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structure inside the soft polymer coating, thus ensuring stable and
consistent device performance (Supplementary Fig. 12). Besides,
the stress–strain analysis revealed that the transverse effective
Young’s modulus of the devices were substantially decreased to as
low as ~137 kPa, which is comparable to the modulus of pure soft
silicone (e.g., Dragon Skin, Smooth-On Inc.), when an ultrasoft
silicone (Ecoflex GEL) with the thickness larger than 1.4 mm is
used as the encapsulating shell (Fig. 3d, e and Supplementary
Fig. 13). Our soft packaging with optimized parameters (i.e.,
Shelltop/bottom= 0.5mm/0.9 mm, Coretop/bottom= 0.5 mm/0.1mm)
based on this mechanical analysis not only makes the overall device
sufficiently thin for full implantation, but also ensures excellent
conformity as well as biomechanical compatibility, all of which are
desirable for subdermal implants.
In addition, the core/shell coating works as a thermal buffer as
well as a fluid barrier that enables thermally safe and waterproof
operation in a biofluid environment. The polymer encapsulation
layers (2 mm for the device body; 7 μm Parylene C for μ-ILEDs)
effectively dissipate the heat generated during wireless charging
and μ-ILED operation, thus preventing brain tissue from being
thermally damaged (Fig. 3f and g and Supplementary Fig. 14).
The maximum temperature increase during device operation
(when the μ-ILEDs are operated at 40 Hz with a 10 ms pulse
width) is minimal (~1.1 °C), thus satisfying the standard for
thermally safe operation of medical devices (i.e., maximum
allowed temperature increment over the body temperature: <2 °C;
ISO 14708-1:2014(E)30). In our durability test inside a saline
solution (0.9%) at two different temperatures, 37 °C and 90 °C
(Supplementary Fig. 15a), the polymer encapsulation provided
excellent waterproofing, which allowed the devices to operate
stably for at least 55 days at <90 °C (Fig. 3h and Supplementary
Fig. 15b). According to the Arrhenius relationship24,31, the
lifetime of the devices is estimated to be longer than a year at
37 °C, which demonstrates their potential usability for chronic
in vivo studies.
Control of the expression of cocaine-induced locomotor sen-
sitization by wireless rechargeable optoelectronic systems in
freely moving rats. In order to test whether our wireless optoe-
lectronic device works functionally and controls behaviors effec-
tively in freely moving animals, we conducted optogenetic
experiments by adopting a well-known cocaine locomotor sen-
sitization scheme, following adeno-associated virus (AAV)-
mediated channelrhodopsin-2 (ChR2) expression in a pre-
limbic (PL) to nucleus accumbens (NAc) circuit and device
implantation (Fig. 4a). For the implantation of the device, suffi-
cient area of the skin above the rat skull was incised to fit the
device (1.4 g; 19 × 12 × 5 mm3; Fig. 1c) and holes were drilled
through the skull for probe injection (Fig. 4b, i). Once the probes
were injected into brain tissue and the device body was mounted
on the skull using a cyanoacrylate adhesive and dental cement,
the opened skin was closed and sutured for full implantation of
the device (Fig. 4b, ii–iii). After a week of recovery (Fig. 4b, iv),
the rats were all healthy and showed natural normal behaviors
(i.e., eating, moving, rearing, and grooming) without any notable
deficits in activity and motor coordination, as shown in Supple-
mentary Movies 4 and 5. Figure 4c shows the locomotor activity
counts obtained during day 1 and 7 in response to intraperitoneal
(IP) injection of saline, cocaine only, and cocaine with photo-
stimulation into the NAc. As well-known32,33 and expected, rats
exposed to daily cocaine showed a more profound sensitized
locomotor response on day 7 compared with day 1 (p < 0.001).
This effect, however, was significantly inhibited by concurrent
photostimulation (470 nm wavelength, 40 Hz with 10 ms pulse
width, 30 s on/off for 5 min with 10 min light-free interval) to the
NAc core. The two-way repeated measures analysis of variance
(ANOVA) conducted on these data indicates that there are
multiple significant effects on locomotor activity of groups
[F(2,12)= 5.75, p < 0.02], days [F(1,12)= 10.04, p < 0.009], and
interactions between groups and days [F(2,12)= 7.54, p < 0.009].
Post hoc Bonferroni comparisons revealed that photostimulation
significantly decreased (p < 0.05) the sensitized locomotor activity
produced by cocaine for a total of 60 min. Time-course analyses
for locomotor activity data obtained at day 7 (Fig. 4d) showed
that the sensitized locomotor-activating-effects of cocaine per-
sisted for approximately the first half hour of testing, and the
ability of optogenetic stimulation to inhibit these effects was
apparent throughout the course of this time. The ANOVA ver-
ified significant effects on locomotor activity of groups [F(2,12)=
6.94, p < 0.02] and time [F(11,132)= 4.64, p < 0.001]. Post hoc
Bonferroni comparisons showed that photostimulation sig-
nificantly decreased (p < 0.05–0.01) the sensitized locomotor
activity caused by cocaine at the 5, 15, and 20 min time points
compared with that observed in rats that received cocaine
only. After the experiments, we verified ChR2 expression in both
PL and NAc core regions where viruses were delivered (Fig. 4e)
and accurate probe implantation in the area right below the
bregma (Fig. 4f) where μ-ILED probes were optimally placed to
illuminate the NAc region toward the anterior direction (see
brain diagram in Fig. 4a). These results clearly indicate that our
wireless device is fully implantable and functionally works well in
freely moving animals, thus confirming its potential for in vivo
optogenetics.
Proof-of-concept demonstration for potential operation in
human brains. The proposed fully implantable, wirelessly
rechargeable, soft optoelectronic system may open new oppor-
tunities for enabling optogenetics in the human brain for ther-
apeutic applications. Figure 5 illustrates the proof-of-concept
demonstration of such system for its potential operation in the
human brain. The fully implantable wireless system (Fig. 5a) can
be used as a user-friendly clinical device that can be controlled by
a simple smartphone manipulation for optical stimulation of the
target neural circuits (left) and that can be wirelessly recharged
using a wireless charging helmet (right, Supplementary Fig. 16a).
Empowered by the miniaturized, battery-integrated wireless
architecture, this system not only requires minimalistic hardware
(i.e., a smartphone) for its control, but also enables its ubiquitous
operation for treatment of brain disorders, thereby making it a
highly practical tool for use in daily life. This feature overcomes
limitations of contemporary battery-free wireless optogenetic
devices, which are restricted to use in animal studies but not
humans, owing to the need for special, bulky wireless power
transfer setup to turn on the devices20–27. Furthermore, with the
wireless charging capability, the device does not require dis-
ruptive multiple surgeries to replace the battery, adding value as a
patient-friendly, chronically implantable device.
Figure 5b shows experiments using a phantom skull (Classic
Human Skull Model 3 part, 3B Scientific) and a phantom brain (a
balloon filled with 0.9% saline solution, Supplementary Fig. 16b)
to study the feasibility of device operation in the human brain. In
this study, we successfully and reliably achieved both wireless
LED controls (scenario 1) and wireless charging (scenario 2).
Note that, for human applications, the device can integrate a
larger size of battery, therefore, the device operation time can be
substantially increased (Supplementary Fig. 9c), compared to the
one measured in scenario 1 in Fig. 5b. Compared with a rat cage
with loop antennas (Fig. 2b, f), the size difference between the
transmitter (in a helmet) and receiver coils (in the implant) was
relatively small, producing a denser magnetic field and thus
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enabling faster wireless charging. Moreover, this wearable
charging helmet approach facilitates efficient wireless power
transfer since the implant always stays at the same location
relative to the transmitting helmet. According to our simulation
(Fig. 5c and Supplementary Fig. 17), wireless charging with
relatively low RF input power (<10W) leads to a small specific
absorption rate (SAR < 1.2W/kg), which satisfies the Federal
Communications Commission (FCC) guideline for biologically
safe operation (SAR of 1.6W/kg; FCC 1.131034). In our
experiment simulating the wireless charging (Supplementary
Fig. 18), this small SAR actually resulted in negligible temperature
increase in phantom brain tissue (<0.1 °C), verifying the RF safety
of our system. In addition, heat generation from the wireless
charging helmet during input power supply was also negligible
(maximum temperature in the antenna structure ~31.0 °C in an
ambient environment), thus ensuring its thermally safe operation
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(Fig. 5d and Supplementary Fig. 19). All these features make this
system an attractive option for potential applications to the
human brain for treatment of neurological or psychiatric
disorders such as Parkinson’s disease35–39.
Discussion
We presented a fully implantable, wirelessly rechargeable, and
smartphone-controlled optogenetic system that combines the
advantages of both battery-powered (i.e., a stable power supply)
and battery-free devices (i.e., a miniaturized design), which allow
reliable, ubiquitous operation and seamless full implantation in
the body, respectively. This device harnesses not only the ability
for simultaneous and selective wireless control of multiple ani-
mals using a readily available smartphone, but also closed-loop
wireless auto-charging capability to enable intervention-less,
long-term in vivo studies. These features, integrated within a
minimalistic and biocompatible platform, can accelerate neu-
roscience research through rapid setup and powerful wireless
control in any in vivo environment, thus contributing to
exploration of brain functions and treatment of various neuro-
degenerative diseases.
Despite the novel features of this device, its design can be
further improved. Although the dimensions (1140 mm2) are
~55% smaller and the weight (1.4 g) is ~42% lighter than our
previous head-mounted neural implant19, which thus allows
subdermal implantation in rats, the current proposed design does
not allow full integration into mice, primarily owing to the
bulkiness of a Bluetooth SoC module and the rechargeable bat-
tery. Using a bare minimum BLE SoC (e.g., SmartBond TINY™
DA14531, Dialog Semiconductor) and ultrathin flexible batteries
(e.g., Polymer Matrix Electrolyte batteries, BrightVolt) will fur-
ther scale down the device size. With integration of these min-
iaturized state-of-the-art electronic components, future devices
will be able to both facilitate its seamless surgical implantation
into animals as small as mice and reduce post-surgical stress in
the animals. Furthermore, although the proposed device is
compatible with X-ray and computed tomography (Fig. 1e and
Supplementary Fig. 4), it is not compatible with magnetic reso-
nance imaging (MRI) yet, primarily because of the presence of
magnetically susceptible metal interconnects and a battery, which
restricts its potential for broad clinical applications. Substituting
these specific parts with non-ferromagnetic components will
ensure safety for real-time MRI studies while the device is
implanted40–42. Likewise, although the core/shell soft polymer
coating structure can enable stable operation of the device within
the body over a year, more advanced hermetic sealing is required
to substantially increase the lifetime of the implantable devices.
Thermally grown silicon dioxide is considered a semi-permanent
biofluid barriers43,44. Adoption of this material for the device
encapsulation can improve the lifetime of the device to several
decades as demonstrated in the previous studies43. In addition,
development and integration of multifunctional flexible
probes17,19,45–47 with high-density, high-rate neural recording
interfaces48,49, and long-life flexible lithium battery50,51 will open
innovative opportunities for chronic, closed-loop neuromodula-
tion by enabling continuous monitoring and precise analyses of
convoluted neural activities as well as feedback-based optogenetic
stimulations using a programmed algorithm.
With these improvements, we believe that the presented
technology will help realize applications of optogenetics in
humans in the near future, allowing highly precise target-specific
treatment of neurodegenerative diseases such as Alzheimer’s and
Parkinson’s35–39. Unlike conventional implantable devices, most
of which require a surgical process to replace exhausted batteries
after several years52,53, using wireless recharging for an implanted
device can eliminate surgical stress for its chronic operation.
Therefore, this technology can bring beneficial impacts for var-
ious implantable devices including deep brain stimulators54,
cardiac pacemakers55, and gastric pacemakers56. Likewise, pow-
erful customizable controls using a readily available smartphone
will significantly facilitate therapeutic interventions. The device
design introduced in this paper represents a generic implantable
device platform with straightforward extensibility. Integration of
advanced functions such as drug delivery and electrophysiological
recording in this soft, fully implantable platform will further
enhance its versatility and utility, broadening opportunities for
in vivo neuroscience and clinical applications.
Methods
Fabrication of fully implantable, wirelessly rechargeable optoelectronic
device. Four individual constituent layers of a fully implantable, wireless
rechargeable optogenetic device were fabricated through a photolithography pro-
cess. Copper traces were patterned on a PI substrate (25 μm thick) at each layer.
The patterned copper traces on the top and bottom layers (both 18 μm thick)
provide the pathways for signaling between the surface-mounted electronic com-
ponents, whereas the copper traces in the middle two layers (both 35 μm thick)
work as a wireless power-scavenging coil antenna in the device, which results in
inductance of ~3.2 μH. A Bluetooth Low Energy System-on-Chip (BLE SoC) and
other electronic components were mounted on the copper electrodes of a flexible
substrate (25 μm thick) after a low-temperature solder paste (T5, SMDLTLFP10T5,
Chip Quik) was applied. They were soldered in a reflow oven (AS-5060, SMTmax)
at a peak temperature of 215 °C for 90 s. μ-ILED probes were fabricated similarly
on a 25 μm-thick flexible PI substrate coated with a 35 μm thick copper layer on
each side (total 130 μm-thick, 300 μm-wide, and 17.5 mm-long). Probes were then
assembled along their length on the flexible circuit after μ-ILEDs (470 nm, TR2227,
Cree) were attached on their tips. Afterward, the device was encapsulated with
PDMS (0.6 mm; Sylgard 184, Dow Corning), Parylene C (7 μm), and Ecoflex GEL
(1.4 mm; Smooth-On). 3D-printed (3DP-310F, CUBICON) molds were used to
encapsulate the device with PDMS and Ecoflex GEL.
RF transmitter for wireless energy transfer. An RF transmitter system consists
of an RF signal generator, an RF power amplifier, a heat sink fan, a DC power
Fig. 4 Control of the expression of cocaine-induced locomotor sensitization using wireless rechargeable optoelectronic implants in freely moving rats.
a Calendar outlining the timeline for the whole experimental procedure. A schematic diagram of the rat brain shows locations for virus injections and μ-
ILED probe insertion. The cocaine injection schedule is also illustrated (right). A sub-group of cocaine-injected rats was photostimulated at days 1 and 7.
b A series of photos for a rat taken during the surgery for device implantation (i–iii) and after recovery from the surgery (iv). c Total locomotor activity
counts observed during the 60min test on days 1 and 7 after saline (white), cocaine only (red), or cocaine with photostimulation (blue) (n= 5). Two
individual data scores overlapped are marked as number 2 next to them. Data were analyzed by two-way repeated ANOVA followed by post hoc
Bonferroni comparisons. ***p < 0.001, cocaine only group on day 7 compared to day 1. †p < 0.05, cocaine group with photostimulation compared with
cocaine only group. Error bars indicate mean + SEM. d Time-course data at day 7, which are shown as locomotor activity counts with 5 min intervals
obtained during the 30min preceding (−30 through 0min) and the 60min following saline (white), cocaine only (red), or cocaine with photostimulation
(blue) (0–60min) (n= 5). The blue bar indicates light stimulation delivered (5, 20, 35, and 50min). ***p < 0.001, **p < 0.01, *p < 0.05, cocaine only
group compared to saline. ††p < 0.01, †p < 0.05, cocaine only group compared with cocaine with photostimulation. Error bars indicate mean + SEM.
e Epifluorescence image of a diagonal brain section with a low magnification (left), showing AAV-mediated EYFP expression in both the PL and NAc core
areas. With a higher magnification (right), it is more evident that EYFP expressed well in cell body regions in the PL (upper right) and even at the axon
terminal location in the NAc core (bottom right). f Representative bright-field image with probe tracks. Most tracks are found in the area behind the NAc.
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supply, three sets of loop antenna with a resonant frequency matching circuit board,
and a custom-made closed-loop automatic electrical switch. It wirelessly transfers
the alternating current to the implanted loop antenna, which in turn supplies the
harvested energy to the rechargeable battery in the device. In order to amplify the
transmitter power, the output of the RF signal generator (Model 3390, Keithley) was
connected to the input of the RF power amplifier (1061-BBM1C3FEL, Empower RF
Systems) via SMA to BNC cable. A DC power supply (DP30-05TP, TOYOTECH)
was used to supply the DC voltage (26-30 V) to the RF power amplifier and the heat
sink fan (LA 21/200 24 V, Fischer Elektronik), which is necessary for cooling the
heat generated from the amplifier. The frequency of the RF signal was set to
6.78MHz, and the power amplitude was set to 0 dBm at the RF signal generator.
Each set of the loop antenna was constructed with a transmitter coil and resonant
frequency matching capacitors, which were connected in series. Output of the RF
power amplifier was linked to each terminal of three sets of loop antennas to supply
an amplified RF signal. The other side of the terminals of the loop antennas were
combined and connected to the custom-made electrical switch, which automatically
controls the current flow to the system based on the battery charge level; that is, it
supplies the current when the battery charge level is <15%, and stops the current
supply when the battery charge level reaches 100%.
Design of wireless energy harvester for battery charging. The wireless energy
harvester of the device consists of a two-layer coil antenna, a voltage-doubler
circuit with a Schottky diode for preventing reverse-flow of the current, and a
Fig. 5 Proof-of-concept demonstration of fully implantable, wireless rechargeable optoelectronic systems for potential operation in a human brain.
a Conceptual illustration showing wireless operation and recharging of the system for chronic human brain applications. A man with the wireless system
implanted in his/her brain can operate it by simple manipulation of a smartphone (left) and recharge the battery by wearing a wireless charging helmet
integrated with an RF transmit coil (right). b Optical images and electrical characteristics of the system, implanted in a model human head constructed with
a phantom skull and brain (a balloon filled with 0.9% saline water), for two different operation scenarios: (1) everyday use with LED operation and (2)
wireless recharging. To simulate everyday use (left), a set of μ-ILED operation (10 and 20 Hz, 10 ms pulse width; ~20min) and rest (~30min) was repeated
until the device battery was almost fully discharged (battery level ~10%). The device was successfully charged by transmitting RF powers (6, 8, and 10W)
using a custom-designed wireless charging helmet (>70% charging in 15 min). c, d Simulated illustration of the specific absorption rate (SAR) over the
human head c and IR image of the RF transmit coil d when a transmitting RF power of 10W at 6.78MHz is supplied to a wireless charging helmet.
Sufficiently low SAR and negligible heat generation induced by the wireless charging helmet verifies biologically safe operation.
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rechargeable LiPo battery (GMB-300910, PowerStream Technology; 12 mAh,
9 mm × 10 mm × 3mm, 0.3 g). A 100 pF capacitor (GRM0335C1E101JA01J,
Murata Electronics; 0.6 mm × 0.3 mm × 0.3 mm) was connected in parallel with a
coil antenna with an inductance of ~3.2 μH to match the resonant frequency of
6.78MHz. Wirelessly received signal was rectified and multiplied through a
voltage-doubler circuit, which was composed of three Schottky diodes (PME-
G4002AESFYL, Nexperia USA Inc.; 0.6 mm × 0.3 mm × 0.3 mm) and two charge
pump capacitors (GRM155R60J475ME47D, Murata Electronics; 4.7 μF, 1.0 mm ×
0.5 mm × 0.7 mm). The stabilized signal was supplied directly to the LiPo battery
for charging, while the RF transmitter system was turned on. The wirelessly
charged LiPo battery supplies the output DC voltage to the BLE SoC (RFD77101,
RF Digital Corporation) through a linear voltage regulator (NCP4624DMU30TCG,
ON Semiconductor; 1.0 mm × 1.0 mm × 0.6 mm) and two decoupling capacitors
(GRM033R61A104KE15D, Murata Electronics; 0.1 μF, 0.6 mm × 0.3 mm ×
0.3 mm).
Electromagnetic simulation of field generation. Commercial software ANSYS
HFSS (ANSYS HFSS 19) was used to simulate the magnetic field density around
the loop antennas and the specific absorption rate (SAR) to a human’s head. The
loop antennas used in the rat cage and the wireless charging helmet were modeled
using the same software. Magnetic fields were plotted at different spatial heights
inside the rat cage model and the wireless charging helmet model in order to show
the overall magnetic field distribution visually. The human’s head model for SAR
simulation was imported from the 3D component library of ANSYS HFSS, which
reflected frequency dependent material properties (i.e., relative permittivity ~581.1
and electrical conductivity ~0.234 s/m).
Measurement of compression–stress curves. The compression–stress curves for
the encapsulated devices were measured using a digital force gauge (M5-100, Mark-
10). The devices were encapsulated in nine different combinations of three
materials (PDMS, Ecoflex, and Ecoflex GEL) and three thicknesses (0.4, 1.4, and
2.4 mm) (Supplementary Fig. 11a). An applied force with increasing compression
was measured and recorded in real time through MESUR Lite software while the
load of the force gauge compressed the device. The stress owing to compression
was calculated by dividing the applied force by the device area.
Measurement of temperature change in brain tissue during μ-ILED operation.
The temperature increment of rat brain tissue during μ-ILED operation was
measured to verify its biothermal compatibility. μ-ILED probes were embedded
under a slice of explanted rat brain (1 mm thick). In order to mimic an in vivo
environment, the measurement was conducted on a hot plate (MSH-50D, DAI-
HAN-brand), in which the temperature was maintained at 36.5 °C, after immersing
the rat brain tissue in saline water (0.9%). The temperature of the rat brain surface
was measured using a longwave infrared thermal camera (A655sc, FLIR) during μ-
ILED operation. μ-ILEDs were operated for a period of 2 min at different fre-
quencies (5, 10, 20, and 40 Hz with 10 ms pulse width) using a custom
smartphone app.
Animal subjects. Male Sprague–Dawley rats weighing 280–310 g (9 weeks old) on
arrival were obtained from Orient Bio Inc. (Seongnam-si, Korea). They were
housed two per cage in a 12-hr light/dark cycle room (lights out at 8:00 pm), and all
experiments were conducted during the day time. Rats had access to food and
water ad libitum at all times. All animal use procedures were conducted according
to an approved Institutional Animal Care and Use Committee protocol of Yonsei
University College of Medicine.
Stereotaxic surgery. One week after arrival, the rats were anesthetized with IP
ketamine (100 mg/kg) and xylazine (6 mg/kg), and placed in a stereotaxic instru-
ment with the incisor bar at 5.0 mm above the interaural line. A pair of bilateral
infusion cannulas (28 gauge; Plastics One, Roanoke, VA) connected to 1 μL syr-
inges (Hamilton, Reno, NV) via PE-20 tubing were angled at 10° to the vertical and
aimed at the NAc core (A/P,+3.2; L, ±2.8; D/V,−7.1 mm from the bregma and
skull)57 delivering retrograde AAV expressing Cre recombinase (AAVrg-hSyn-Cre,
viral titer 7 × 10¹² vg/mL) (Addgene, Watertown, MA; the Addgene plasmid
#105553 used to prepare this virus was a gift from Dr. James M. Wilson) and at the
PL (A/P+3.2, L ±1.3, D/V−4.1 mm from the bregma and skull) delivering Cre-
dependent AAV expressing ChR2-EYFP or EYFP alone (AAV5-EF1α-DIO-
hCHR2-(H134R)-EYFP or AAV5-EF1α-DIO-EYFP, viral titer 1 × 10¹³ vg/mL)
(Addgene, Watertown, MA; the Addgene plasmids #20298 and #27056 used to
prepare these viruses were gifts from Dr. Karl Deisseroth). In all, 1 μL syringes were
placed on an infusion pump (KD Scientific, Holliston, MA) and the virus was
infused at a rate of 0.1 μL/min for 5 min with an additional 5 min allowed for its
diffusion. The incised skin covering the skull was fixed with surgical staplers and
the rats were returned to their home cages for recovery and virus expression. After
two weeks, the rats were re-anesthetized with IP ketamine (100 mg/kg) and xyla-
zine (6 mg/kg), and placed in a stereotaxic instrument with the incisor bar not
raised. A wirelessly rechargeable optoelectronic device was placed directly onto the
rat skull and bilateral μ-ILED probes were vertically inserted aiming at the far
posterior site of the NAc right below the bregma (A/P+0.5, L ±2.0, D/V−7.5 mm
from the bregma and skull)58. The device was helped to adhere to the skull with a
cyanoacrylate adhesive (Henkel, Dusseldorf, Germany), and a dental adhesive resin
cement (Sun Medical, Shiga, Japan). The incised skin was closed with non-
absorbable sutures with additional help of a topical skin adhesive (Ethicon, Som-
erville, MA) and the rats were returned to their home cages for one week of
recovery.
Drugs. Cocaine hydrochloride was purchased from Belgopia (Louvain-La-
Neuve, Belgium). It was dissolved in sterile 0.9% saline to a final concentration of
15 mg/mL.
Locomotor activity. Locomotor activity was measured with a bank of nine activity
boxes (35 × 25 × 40 cm3) (IWOO Scientific Corporation, Seoul, Korea) made of
translucent Plexiglas. Each box was individually housed in a polyvinyl chloride
plastic sound-attenuating cubicle. The floor of each box consisted of 21 stainless
steel rods (5 mm diameter) spaced 1.2 cm apart center-to-center. Two infrared light
photobeams (Med Associates, St. Albans, VT), positioned 4.5 cm above the floor
and spaced evenly along the longitudinal axis of the box, estimated horizontal
locomotor activity. Locomotor activity was counted only when two beams were
consecutively interrupted. In this way, any confounding measures like grooming in
a spot covering just a single beam was avoided from the counts.
Cocaine sensitization. About 1 week after probe implantation surgery, rats were
randomly assigned to three groups. Rats in one group were administered with
saline once daily and the ones in the other two groups with cocaine (15 mg/kg, IP)
for 7 days. Locomotor activities after saline injection, or cocaine with or without
optical stimulation, were measured in activity boxes only on days 1 and 7, whereas
no activities were measured during home cage-injections for the other days. In this
way, administering cocaine in different places (i.e., in the activity boxes for the first
and the last injections and in home cages for the other injections) helped to avoid
any confounding effects of conditioning development. This commonly used pro-
cedure is well known to produce enduring sensitization of the locomotor response
to cocaine32,33.
One day prior to day 1, in order for the rats to adjust to the new procedure and
environment, all the rats were first put in plastic restrainers for 30 min and then
placed in activity boxes for another 30 min. They were all administered saline and
returned to the activity boxes for an additional 60 min. On days 1 and 7, all the rats
were put in plastic restrainers for 30 min, and only a sub-group of cocaine
(cocaine+ optical stimulation) was wirelessly charged during this time, followed by
habituation for 30 min in activity boxes. Then, the rats were administered saline, or
cocaine with or without optical stimulation, and their locomotor activities were
measured for 60 min. The implanted optoelectronic devices were paired with a
smartphone through Bluetooth and operated using a customized smartphone app.
A sub-group of cocaine with optical stimulation received repeated blue lights
(470 nm) for 5 min (40 Hz, 30 s on/off) with an interval of a light-free period for
10 min throughout a total of 60 min locomotor activity measurement.
Tissue preparation and histology. After completion of the behavioral experi-
ments, the rats were deeply anesthetized with ketamine (100 mg/kg) and xylazine
(6 mg/kg) and then perfused transcardially with 10 mM phosphate-buffered saline
(PBS, pH 7.4) followed by 4% paraformaldehyde (PFA) solution in 10 mM PBS
(pH 7.4). Their brains were removed and further post-fixed in 4% PFA at 4 °C for
24 h, followed by keeping them in a 30% sucrose solution for 72 h. Then, the brains
were embedded in an O.C.T. compound (Tissue-Tek, Torrance, CA), frozen on dry
ice, and stored at −80 °C. One set of coronal sections (100 μm) were made from the
anterior portion, including the target areas for virus injections of frozen brain
tissues, and their captured fluorescent images were analyzed for ChR2-EYFP
expression. Another set of coronal sections (50 μm) were made from the sur-
rounding area, including target areas for probe implantation of frozen brain tissues,
and their bright-field images were analyzed for a μ-ILED probe track with reference
to a stereotaxic atlas. The sections were all cover-slipped with a Vectashield
mounting medium (Vector Laboratories, UK) before analysis, and all images were
captured with a DP71 digital microscope camera attached to a fluorescent
microscope (Olympus, Japan).
In vivo biocompatibility studies. Twelve rats were anesthetized with IP ketamine
(100 mg/kg) and xylazine (6 mg/kg) for device implantation. Two types of device
encapsulation were used for comparison: one is PDMS alone (a well-known bio-
compatible silicone material (USP class VI) and the other is Ecoflex GEL sur-
rounding the PDMS/Parylene C bilayer coating, and each of them was implanted
subdermally under the rat scalp. The device was adhered to the skull with cya-
noacrylate adhesive (Henkel, Dusseldorf, Germany) and the incised skin was closed
with non-absorbable sutures. On day 3, 6, 10 after the surgery, the rats were
anesthetized and hair on the scalp around the surgery site was removed by a
depilatory cream (Nair, Ewing, NJ). Then, rats were perfused transcardially with
10 mM phosphate-buffered saline (PBS, pH 7.4) followed by 3.7% formaldehyde
solution. The scalp tissue right above the device was excised out as a rectangle (5 ×
10 mm) and post-fixed in 3.7% formaldehyde for 24 h. The tissue samples were
embedded in paraffin and cut with 4 μm sections. The sections were then stained
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with hematoxylin and eosin (H & E). Digital images (×10 magnification) were
obtained using DP71 digital microscope camera attached to a microscope
(Olympus, Japan). Six representative areas were taken per rat and analyzed using
Image J for the thickness of loose areolar tissue, which is the sub-area of the scalp
directly contacted with the device.
Statistical analysis. Statistical analyses were performed using the Sigma Plot
version 12.0 (Systat Software, San Jose, CA). The locomotor activity counts were
analyzed with two-way repeated measures ANOVA, followed by Bonferroni post
hoc comparisons. Differences between experimental conditions were considered
statistically significant when p < 0.05.
Reporting summary. Further information on the research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the plots within this paper and other findings of this study are
available from the corresponding author upon reasonable request.
Code availability
The software code used for wireless optoelectronic systems is available from the
corresponding author upon reasonable request.
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